These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1314649)

  • 1. Effect of enzyme and ligand protonation on the binding of folates to recombinant human dihydrofolate reductase: implications for the evolution of eukaryotic enzyme efficiency.
    Appleman JR; Tsay JT; Freisheim JH; Blakley RL
    Biochemistry; 1992 Apr; 31(14):3709-15. PubMed ID: 1314649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic investigation of the functional role of phenylalanine-31 of recombinant human dihydrofolate reductase.
    Tsay JT; Appleman JR; Beard WA; Prendergast NJ; Delcamp TJ; Freisheim JH; Blakley RL
    Biochemistry; 1990 Jul; 29(27):6428-36. PubMed ID: 2207084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13C and 15N nuclear magnetic resonance evidence that the active site carboxyl group of dihydrofolate reductase is not involved in the relay of a proton to substrate.
    Blakley RL; Appleman JR; Freisheim JH; Jablonsky MJ
    Arch Biochem Biophys; 1993 Nov; 306(2):501-9. PubMed ID: 8105754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH dependence of enzyme reaction rates and deuterium isotope effects on the reduction of a new mechanism-based substrate by dihydrofolate reductase DHFR.
    Jeong SS; Gready JE
    Biochemistry; 1995 Mar; 34(11):3734-41. PubMed ID: 7893670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human dihydrofolate reductase: reduction of alternative substrates, pH effects, and inhibition by deazafolates.
    Williams EA; Morrison JF
    Biochemistry; 1992 Jul; 31(29):6801-11. PubMed ID: 1637816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships and pH dependence of binding of 8-alkyl-N5-deazapterins to dihydrofolate reductase.
    Ivery MT; Gready JE
    J Med Chem; 1994 Nov; 37(24):4211-21. PubMed ID: 7990119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual transient- and steady-state kinetic behavior is predicted by the kinetic scheme operational for recombinant human dihydrofolate reductase.
    Appleman JR; Beard WA; Delcamp TJ; Prendergast NJ; Freisheim JH; Blakley RL
    J Biol Chem; 1990 Feb; 265(5):2740-8. PubMed ID: 2303423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ionization state and pKa of pterin-analogue ligands bound to dihydrofolate reductase.
    Jeong SS; Gready JE
    Eur J Biochem; 1994 May; 221(3):1055-62. PubMed ID: 8181462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of long-lived bound water molecules in complexes of human dihydrofolate reductase with methotrexate and NADPH.
    Meiering EM; Wagner G
    J Mol Biol; 1995 Mar; 247(2):294-308. PubMed ID: 7707376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociation constants for dihydrofolic acid and dihydrobiopterin and implications for mechanistic models for dihydrofolate reductase.
    Maharaj G; Selinsky BS; Appleman JR; Perlman M; London RE; Blakley RL
    Biochemistry; 1990 May; 29(19):4554-60. PubMed ID: 2372539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pH-dependence of the binding of dihydrofolate and substrate analogues to dihydrofolate reductase from Escherichia coli.
    Stone SR; Morrison JF
    Biochim Biophys Acta; 1983 Jun; 745(3):247-58. PubMed ID: 6344924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: catalytic properties and interaction with antifolates.
    Margosiak SA; Appleman JR; Santi DV; Blakley RL
    Arch Biochem Biophys; 1993 Sep; 305(2):499-508. PubMed ID: 8373187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual binding stoichiometries and cooperativity are observed during binary and ternary complex formation in the single active pore of R67 dihydrofolate reductase, a D2 symmetric protein.
    Bradrick TD; Beechem JM; Howell EE
    Biochemistry; 1996 Sep; 35(35):11414-24. PubMed ID: 8784197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How dihydrofolate reductase facilitates protonation of dihydrofolate.
    Rod TH; Brooks CL
    J Am Chem Soc; 2003 Jul; 125(29):8718-9. PubMed ID: 12862454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of conversion of phenylalanine-31 to leucine on the function of human dihydrofolate reductase.
    Prendergast NJ; Appleman JR; Delcamp TJ; Blakley RL; Freisheim JH
    Biochemistry; 1989 May; 28(11):4645-50. PubMed ID: 2765506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ternary crystal complexes of F31 variants of human dihydrofolate reductase with NADPH and a classical antitumor furopyrimidine.
    Cody V; Galitsky N; Luft JR; Pangborn W; Blakley RL; Gangjee A
    Anticancer Drug Des; 1998 Jun; 13(4):307-15. PubMed ID: 9627670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase.
    Hicks SN; Smiley RD; Hamilton JB; Howell EE
    Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering specificity for folate into dihydrofolate reductase from Escherichia coli.
    Posner BA; Li L; Bethell R; Tsuji T; Benkovic SJ
    Biochemistry; 1996 Feb; 35(5):1653-63. PubMed ID: 8634297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinetic mechanism of wild-type and mutant mouse dihydrofolate reductases.
    Thillet J; Adams JA; Benkovic SJ
    Biochemistry; 1990 May; 29(21):5195-202. PubMed ID: 1974147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR solution structure of the antitumor compound PT523 and NADPH in the ternary complex with human dihydrofolate reductase.
    Johnson JM; Meiering EM; Wright JE; Pardo J; Rosowsky A; Wagner G
    Biochemistry; 1997 Apr; 36(15):4399-411. PubMed ID: 9109647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.